Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

EWA A BIALIKIEWICZ

Allopathic & Osteopathic Physicians Family Medicine

NPI
1114972312
CMS profile
141013
Location
PORT CHARLOTTE, FL

General Payments · PY2018–2019

$1,118.24

  • Reported across 105 records
  • CMS publication 2026-01-23

Latest program year · PY2019

$240.36

18 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2019 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $240.36 18

By paying entity

PY2019 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $877.88 87
PY2019 $240.36 18

Payment records · PY2019 (18)

Sorted by paying entity, then date · as published by CMS

Program year 2019 2018 Record-level detail is published for PY2019; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $14.14 02/25/2019 Food and Beverage Undisputed 01/23/2026 685644209 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.02 02/26/2019 Food and Beverage Undisputed 01/23/2026 700185257 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.46 03/13/2019 Food and Beverage Undisputed 01/23/2026 700185255 CMS
GlaxoSmithKline, LLC. $12.09 02/01/2019 Food and Beverage Undisputed 01/23/2026 670598639 CMS
GlaxoSmithKline, LLC. $12.44 05/02/2019 Food and Beverage Undisputed 01/23/2026 671457873 CMS
Grifols USA, LLC $18.70 03/18/2019 Food and Beverage Undisputed 01/23/2026 692581725 CMS
Janssen Pharmaceuticals, Inc $11.70 04/15/2019 Food and Beverage Undisputed 01/23/2026 658330921 CMS
Merck Sharp & Dohme Corporation $13.14 03/06/2019 Food and Beverage Undisputed 01/23/2026 695311677 CMS
Novartis Pharmaceuticals Corporation $14.81 03/11/2019 Food and Beverage Undisputed 01/23/2026 658925659 CMS
Novo Nordisk Inc $10.89 04/10/2019 Food and Beverage Undisputed 01/23/2026 669531653 CMS
PFIZER INC. $13.22 02/06/2019 Food and Beverage Undisputed 01/23/2026 673290507 CMS
Sunovion Pharmaceuticals Inc. $11.65 01/23/2019 Food and Beverage Undisputed 01/23/2026 688179493 CMS
Sunovion Pharmaceuticals Inc. $11.73 02/28/2019 Food and Beverage Undisputed 01/23/2026 688179495 CMS
Sunovion Pharmaceuticals Inc. $13.68 03/08/2019 Food and Beverage Undisputed 01/23/2026 688179497 CMS
Sunovion Pharmaceuticals Inc. $8.35 04/12/2019 Food and Beverage Undisputed 01/23/2026 688179499 CMS
Takeda Pharmaceuticals U.S.A., Inc. $6.14 01/22/2019 Food and Beverage Undisputed 01/23/2026 681700047 CMS
Takeda Pharmaceuticals U.S.A., Inc. $12.50 02/05/2019 Food and Beverage Undisputed 01/23/2026 681966991 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.70 03/19/2019 Food and Beverage Undisputed 01/23/2026 681824683 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019
Source files
Dataset page · Bulk file · PY2018 , PY2019
Generated from
OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.